Annals of Coloproctology

The Korean Society of Coloproctology (대한대장항문학회)
권호 표지
DOI QR코드

DOI QR Code

Relationship between Metabolic Syndrome and MTHFR Polymorphism in Colorectal Cancer

  • Kang, Bong-Su (Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Ahn, Dae-Ho (Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Kim, Nam-Keun (Department of Institute for Clinical Research, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Kim, Jong-Woo (Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine)
  • Published : 2011.04.30
⟨ Previous Next ⟩

Abstract

Purpose: There have been studies on the relations between metabolic syndrome and colorectal cancer or on the relations between methylenetetrahydrofolate reductase (MTHFR) polymorphism and colorectal cancer, but reports on the relationship between metabolic syndrome, MTHFR polymorphism and colorectal cancer all together are rare. The aim of this study is to find the interrelation between metabolic syndrome and MTHFR polymorphism in colorectal cancer. Methods: This study investigated 255 colorectal cancer patients (cancer group) who underwent surgery in our hospital from March 2003 to December 2008 and compared those patients to 488 healthy patients (control group). The diagnostic criterion for metabolic syndrome was based on the National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATP III), and the MTHFR 677 polymorphism was analyzed. Results: When colorectal cancer patients and patients in the control group were classified as MTHFR 677 subtypes, there was no difference between the two groups: CC 87 (34.1%), CT 134 (52.6%), and TT 34 (13.3%) for the cancer group and CC 145 (32.4%), CT 238 (53.1%), and TT 65 (14.5%) for the control group. Distributions of MTHFR 677C/T genotype and allele frequencies in the individuals with and without metabolic syndrome in the cancer group showed no differences. Moreover, we could find no differences in distributions of MTHFR 677C/T genotypes in the clinical and the biomedical variables of individuals with and without metabolic syndrome in the cancer group. Conclusion: Our results show no relation between metabolic syndrome and MTHFR polymorphism in colorectal cancer. However, a further prospective study, based on a precise diagnostic criterion for metabolic syndrome, is needed.

Keywords

References

  1. Ministry of Health and Welfare. Annual report of the national cancer registry in Korea 2006 [Internet]. Seoul: Ministry of Health and Welfare; 2009 [cited 2011 Mar 20]. Available from: http://library. mw.go.kr/skyblueopen/users/bogun/PdfViewer.aspx?mastid =63250&pdf_url=K0031255.pdf.
  2. Reaven GM, Chen YD. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988;4:639-52. https://doi.org/10.1002/dmr.5610040703
  3. Inoue S, Zimmet P. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd; 2000.
  4. Lym YL, Hwang SW, Shim HJ, Oh EH, Chang YS, Cho BL. Prevalence and risk factors of the metabolic syndrome as defined by NCEP-ATP III. J Korean Acad Fam Med 2003;24:135-43.
  5. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 2006;15:2391-7. https://doi.org/10.1158/1055-9965.EPI-06-0391
  6. Ju JH, Lim TK, Shin KK, Park KH, Park KC, Kim MJ, et al. Relationship between the metabolic syndrome and colorectal polyps. J Korean Acad Fam Med 2007;28:134-40.
  7. Kim HS, Kang BS, Kim JW, Ahn DH, Bae SJ, Kim NG. Polymorphism of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and microsatellite instability (MSI) in mucinous colorectal cancer. J Korean Soc Coloproctol 2008;24:329-36. https://doi.org/10.3393/jksc.2008.24.5.329
  8. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9. https://doi.org/10.1038/25292
  9. Oron-Herman M, Rosenthal T, Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism 2003;52:1491-5. https://doi.org/10.1016/S0026-0495(03)00262-2
  10. Ellingrod VL, Miller DD, Taylor SF, Moline J, Holman T, Kerr J. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr Res 2008;98:47-54.
  11. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55:285-91. https://doi.org/10.1136/gut.2005.073163
  12. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003;46:595-607. https://doi.org/10.1007/s00125-003-1109-5
  13. Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003;108:1546-51. https://doi.org/10.1161/01.CIR.0000088846.10655.E0
  14. Chang SC, Lin PC, Lin JK, Yang SH, Wang HS, Li AF. Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis 2007;22:483-9. https://doi.org/10.1007/s00384-006-0190-x
  15. Shannon B, Gnanasampanthan S, Beilby J, Iacopetta B. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 2002;50:520-4. https://doi.org/10.1136/gut.50.4.520
  16. Eaton AM, Sandler R, Carethers JM, Millikan RC, Galanko J, Keku TO. 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2023-9. https://doi.org/10.1158/1055-9965.EPI-05-0131

Cited by

  1. Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians vol.33, pp.6, 2012, https://doi.org/10.1007/s13277-012-0463-7
  2. MTHFR C677T Polymorphism and Colorectal Cancer Risk in Asians, a Meta-analysis of 21 Studies vol.13, pp.4, 2012, https://doi.org/10.7314/apjcp.2012.13.4.1203
  3. Metabonomic Variations Associated with AOM-Induced Precancerous Colorectal Lesions and Resveratrol Treatment vol.11, pp.6, 2011, https://doi.org/10.1021/pr300284h
  4. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies vol.39, pp.10, 2012, https://doi.org/10.1007/s11033-012-1832-4
  5. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with colorectal cancer risk: A meta-analysis vol.1, pp.5, 2011, https://doi.org/10.3892/br.2013.134
  6. Risk of prostate cancer and thrombosis-related factor polymorphisms vol.2, pp.1, 2011, https://doi.org/10.3892/br.2013.180
  7. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies vol.41, pp.7, 2011, https://doi.org/10.1007/s11033-014-3337-9
  8. Associations of MTHFR C677T and MTRR A66G Gene Polymorphisms with Metabolic Syndrome: A Case-Control Study in Northern China vol.15, pp.12, 2011, https://doi.org/10.3390/ijms151221687
  9. Association between methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and risk of ischemic stroke in North Indian population: A hospital based case-control study vol.17, pp.4, 2011, https://doi.org/10.1016/j.ejmhg.2016.01.001
  10. Associations of MTHFR C677T polymorphism with insulin resistance, results of NURSE Study (Nursing Unacquainted Related Stress Etiologies) vol.16, pp.None, 2017, https://doi.org/10.1186/s40200-017-0303-9
  11. Associations of MTRR and TSER polymorphisms related to folate metabolism with susceptibility to metabolic syndrome vol.41, pp.8, 2011, https://doi.org/10.1007/s13258-019-00840-8